Veeva Systems (NYSE: VEEV) has announced that 18 of the top 20 medical technology (medtech) companies are utilising its Veeva Development Cloud and Veeva Commercial Cloud applications to enhance processes throughout the medtech product lifecycle. This strategic adoption underscores a growing trend within the medtech industry to transition to connected applications on a single cloud platform to meet the increasing demands for faster time-to-market and improved operational efficiency.
Veeva MedTech currently supports over 125 customers, leveraging its deep industry expertise and technological capabilities from the initial stages of product ideation through to commercialisation. As the medtech landscape evolves, companies are recognising the necessity of modernising their systems to streamline key processes and maintain competitive advantage.
“With dozens of studies across hundreds of global sites, simplifying clinical operations with unified document management and streamlined workflows is a top priority,” stated Matt Christensen, senior vice president at Smith+Nephew. He emphasised that employing Veeva MedTech’s unified clinical solution enhances transparency, ensures the integrity of study files, and accelerates trial timelines.
The Veeva MedTech suite offers comprehensive product lifecycle management through its applications, including Veeva Vault Clinical, Veeva Vault Regulatory Information Management (RIM), Veeva Vault Quality, and Veeva Vault Commercial. These advanced tools are designed with medtech industry best practices in mind, enabling users to access real-time insights, make data-driven decisions, automate processes, and ensure inspection readiness. This comprehensive approach significantly reduces manual tasks and fosters improved collaboration across teams, ultimately driving growth, cost efficiency, and compliance.
“The momentum we are witnessing highlights the substantial progress the global medtech industry has made in modernising its systems,” remarked Seth Goldenberg, vice president of Veeva MedTech. “By standardising on Veeva applications, leading medtech companies are laying a solid foundation across the product lifecycle that will enable future advancements. Our commitment remains focused on learning from these top tier medtech leaders to further streamline processes, delivering innovative new devices and diagnostics to patients in need.”
To foster collaboration and knowledge-sharing within the industry, Veeva MedTech will host its annual EU Summit from November 5 to 7 in Amsterdam. The event is set to welcome over 200 professionals from the medtech sector who will network, share best practices, and gain insights from industry leaders, including representatives from Bio-Rad Laboratories, Philips, and ZEISS Medical Technology.
The summit aims to create a platform for medtech professionals to engage in meaningful discussions about the challenges and opportunities within the industry, exploring the latest innovations and trends. Attendees will have the chance to hear from experts and contribute to the evolving conversation surrounding the future of medtech and its impact on patient care.
As the industry continues to embrace technological advancements and modern practices, Veeva Systems is positioning itself as a key player in shaping the future of medtech, driving efficiency, and enabling companies to respond effectively to market demands.
